Interleukin-2 for use in treating autism spectrum disorder
US-2026092095-A1 · Apr 2, 2026 · US
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 83689520 |
| Family type | — |
| Earliest priority | Sep 12, 2022 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2026092095A1 — Interleukin-2 for use in treating autism spectrum disorder |
Best representative member for this family based on priority and filing country.
US2026092095A1 — Interleukin-2 for use in treating autism spectrum disorder (published Apr 2, 2026)
Related publications in this family.
US-2026092095-A1 · Apr 2, 2026 · US